NCT06416319

Preoperative Physical Activity Improvement With the Use of Activity Trackers Before Radical Cystectomy (PreAct)

Preoperative Physical Activity Improvement With the Use of Activity Trackers in Patients Undergoing Radical Cystectomy for Bladder Cancer: A Randomized Controlled Trial (PreAct)
Universitätsmedizin Mannheim·ClinicalTrials.gov·device·Device trialRecruiting
View on ClinicalTrials.gov
Study focus
Drug/Device/Intervention
Daily Activity Goal and Feedback
Study type
Interventional
Intervention type
device
Sponsor & location
Primary sponsor
Universitätsmedizin Mannheim
Location
Mannheim,München, Germany
Timeline & enrollment
Phase
N/A
Start date
Mar 14, 2023
End date
Mar 14, 2026
Enrollment
164 participants
Primary outcome

Number of steps per day

Summary

A bicentric, open-label randomised controlled trial (RCT) is planned to investigate whether
 the use of fitness wristbands in a defined preoperative period prior to radical cystectomy
 leads to a preoperative increase in participants' physical activity (number of steps per day)
 up to the day of radical cystectomy.

ICD-10 classifications
Malignant neoplasm of bladderMalignant neoplasm: Bladder, unspecifiedMalignant neoplasm: Overlapping lesion of bladderMalignant neoplasm: Dome of bladderSecondary malignant neoplasm of bladder and other and unspecified urinary organs
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06416319
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT06416319 through Pure Global AI's free database. This phase not specified trial is sponsored by Universitätsmedizin Mannheim and is currently Recruiting. The study focuses on Bladder Cancer,Bladder Neoplasm,Bladder Urothelial Carcinoma. Target enrollment is 164 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.